Healthpeak Properties, Inc.
DOCReal EstateNASDAQREIT - Healthcare Facilities · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHealthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. The $13.65B market capitalization puts DOC squarely in large-cap range for its industry. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Market Cap
$13.65B
Beta
0.99
P/E (TTM)
55.00
P/E (Fwd)
137.50
EPS (TTM)
$0.35
EPS (Fwd)
$0.14
ROE
3.0%
ROA
1.5%
Cash
$1.64B
Total Debt
$10.32B
Free CF
$1.65B
52W Change
1.0%
Annual Financials
Cash vs Debt
Where DOC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, DOC finished 4.56% below its 150-day moving average ($19.28) and 0.81% below its 200-day moving average ($18.55). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is DOC overbought or oversold?
At the October 20, 2026 close, DOC's RSI(14) was 26.4, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, DOC has $1.64B in cash with $10.32B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $1.65B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 3.0% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.06B (2022) to $2.82B (2025), reflecting a 37% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. At over 50x earnings, DOC carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. No single metric tells the full story. Reviewing DOC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.